Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/1996
05/21/1996US5519118 Human MDM2 protein involved in human tumors
05/21/1996US5519117 Polypeptide sequences as anticarcinogenic agents
05/21/1996US5519115 Reverse antimicrobial peptides
05/21/1996US5519114 Retroviral superantigens, superantigen peptides, and methods of use
05/21/1996US5519003 WD-40-derived peptides and uses thereof
05/21/1996US5518913 Genetic engineering
05/21/1996US5518912 A pure enzyme endogenous to biological cells of the skin of xenopus
05/21/1996US5518911 Human PAK65
05/21/1996US5518909 Flexion enhanced transfection of genetic material
05/21/1996US5518908 Method of controlling insects
05/21/1996US5518907 Cloning and expression in Escherichia coli of the Alcaligenes eutrophus H16 poly-beta-hydroxybutyrate biosynthetic pathway
05/21/1996US5518906 Production of d-pantoic acid and d-pantothenic acid
05/21/1996US5518900 Method for generating single-stranded DNA molecules
05/21/1996US5518897 Controlling mosquitoes and black flies, proteins, insecticides
05/21/1996US5518885 ERBB2 promoter binding protein in neoplastic disease
05/21/1996US5518884 Hybridization probes, amplification primers
05/21/1996US5518881 Transfected cell lines expressing autoantigens and their use in immunoassays for the detection of autoimmune disease
05/21/1996US5518880 X-linked severe combined immunodeficiency diseases
05/21/1996US5518723 Vaccines containing antibodies and epitopes
05/21/1996CA2064092C Efficient directional genetic cloning system
05/21/1996CA1338338C Process for the preparation of foreign proteins in streptomycetes
05/19/1996CA2163136A1 Human flavin-containing monooxygenase
05/18/1996CA2162986A1 Proteins having fibrinolytic and coagulation-inhibiting properties
05/17/1996WO1996014579A1 The use of a bmp protein receptor complex for screening bone metabolism actives and cells co-transfected with a type ii bmp receptor and a type i bmp receptor
05/17/1996WO1996014437A2 Detection of human retrovirus infection
05/17/1996WO1996014436A1 Method for making recombinant yeast artificial chromosomes
05/17/1996WO1996014435A1 USE OF NEURITE LOCALIZED mRNAs FOR MEDICAL DIAGNOSIS AND THERAPEUTICS
05/17/1996WO1996014426A1 Method of synthesizing a fluorescently labeled protein
05/17/1996WO1996014424A1 Dna transfer method
05/17/1996WO1996014423A1 Aedes aegypti densovirus expression system
05/17/1996WO1996014422A1 Process for bacterial production of heterologous polypeptides with disulphide bonds
05/17/1996WO1996014421A2 Tomato fruit promoters
05/17/1996WO1996014420A1 Inducible cell ablation
05/17/1996WO1996014419A1 MUTANT MONO-OXYGENASE CYTOCHROME P-450¿cam?
05/17/1996WO1996014418A1 Respiratory syncytial virus protein g expressed on bacterial membrane
05/17/1996WO1996014416A1 Method for enhancing the immunogenicity of an immunogenic compound or hapten, and use thereof for preparing vaccines
05/17/1996WO1996014415A1 Carrier protein having an adjuvant effect, immunogenic complex containing same, preparation method therefor, nucleotide sequence and vaccine
05/17/1996WO1996014414A1 Genetic control of flowering
05/17/1996WO1996014413A1 Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in aspergillus
05/17/1996WO1996014412A2 cDNA ENCODING A BMP TYPE II RECEPTOR
05/17/1996WO1996014411A1 Methods for the diagnosis of glaucoma
05/17/1996WO1996014410A1 Human scf, a splice variant thereof, its pharmaceutical use
05/17/1996WO1996014409A1 Production of recombinant peptides as natural hydrophobic peptide analogues
05/17/1996WO1996014408A2 Nucleotide sequence encoding the enzyme i-scei and the uses thereof
05/17/1996WO1996014407A1 Recombinant alternaria alternata allergens
05/17/1996WO1996014406A1 Method of preparing oligonucleotide probes or primers, vector therefor and use thereof
05/17/1996WO1996014404A1 Tripeptidyl aminopeptidase
05/17/1996WO1996014401A1 Transgenic organisms and their uses
05/17/1996WO1996014400A1 Human cell-lines
05/17/1996WO1996014397A1 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases
05/17/1996WO1996014396A1 Neural cultures
05/17/1996WO1996014395A1 Cultured eukaryotic cell dissociation method
05/17/1996WO1996014394A1 Human dna ligase iii
05/17/1996WO1996014341A1 Monoclonal antibody capable of binding to pna/nucleic acid complexes
05/17/1996WO1996014340A1 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof
05/17/1996WO1996014339A1 Antibodies
05/17/1996WO1996014335A1 Cartilage-derived morphogenetic proteins
05/17/1996WO1996014334A1 IDENTIFICATION OF THE p21WAF1-PCNA INTERACTION SITE AND THERAPEUTIC APPLICATIONS THEREOF
05/17/1996WO1996014332A1 Retroviral vectors containing recombinant cmv-ie/hiv-tar/moloney murine leukemia virus long terminal repeats
05/17/1996WO1996014331A1 Modified neuropeptide y receptors
05/17/1996WO1996014330A1 Amino acid nucleic acids
05/17/1996WO1996014329A1 Sugar modified nucleosides and their use for synthesis of oligonucleotides
05/17/1996WO1996014328A1 Tumor necrosis factor-gamma
05/17/1996WO1996014277A1 Synthesis of 35s-labeled oligonucleotides with 3h-1,2-benzodithiol-3-1,1-dioxide
05/17/1996WO1996014111A1 Golf club receptacle
05/17/1996WO1996014088A1 Attenuated canine parvovirus vaccine
05/17/1996WO1996014087A1 Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector
05/17/1996WO1996014082A1 Methods and kits using macrophage stimulating protein
05/17/1996WO1996014077A1 Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
05/17/1996WO1996014074A1 Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
05/17/1996WO1996014073A1 Treatment of urogenital cancer with boron neutron capture therapy
05/17/1996WO1996014061A1 Novel adenoviral vectors, packaging cell lines, recombinant adenoviruses and methods
05/17/1996WO1996011279A3 Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule b7 gene in a recombinant virus expressing system
05/17/1996WO1996010639A3 The taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma
05/17/1996WO1996010419A3 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule
05/17/1996WO1996008568A3 Cloning and expression of cdna for human dihydropyrimidine dehydrogenase
05/17/1996WO1996008566A3 Process for producing polyhydroxylic fatty acids and recombinant bacterial strains for carrying out the process
05/17/1996WO1996007392A3 Oligonucleotide prodrugs
05/17/1996WO1996002646A3 Growth control for cells encapsulated within bioartificial organs
05/17/1996CA2307311A1 Sugar modified nucleosides and their use for synthesis of oligonucleotides
05/17/1996CA2204637A1 Method of preparing oligonucleotide probes or primers, vector therefor and use thereof
05/17/1996CA2204619A1 Method for enhancing the immunogenicity of an immunogenic compound or hapten, and use thereof for preparing vaccines
05/17/1996CA2204618A1 Respiratory syncytial virus protein g expressed on bacterial membrane
05/17/1996CA2204511A1 Production of recombinant peptides as natural hydrophobic peptide analorues
05/17/1996CA2204510A1 Carrier protein having an adjuvant effect, immunogenic complex containing same, preparation method therefor, nucleotide sequence and vaccine
05/17/1996CA2204491A1 Modified neuropeptide y receptors
05/17/1996CA2204428A1 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases
05/17/1996CA2204380A1 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof
05/17/1996CA2204372A1 Detection of human retrovirus infection
05/17/1996CA2204362A1 Recombinant alternaria alternata allergens
05/17/1996CA2204359A1 Method for making recombinant yeast artificial chromosomes
05/17/1996CA2204246A1 Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in aspergillus
05/17/1996CA2204169A1 Aedes aegypti densovirus expression system
05/17/1996CA2204109A1 Neural cultures
05/17/1996CA2204032A1 Tomato fruit promoters
05/17/1996CA2203935A1 Transgenic organisms and their uses
05/17/1996CA2203909A1 Identification of the p21waf1-pcna interaction site and therapeutic applications thereof
05/17/1996CA2203651A1 Dna ligase iv
05/17/1996CA2203630A1 Human cell-lines
05/17/1996CA2203499A1 Retroviral vectors containing recombinant cmv-ie/hiv-tar/moloney murine leukemia virus long terminal repeats
1 ... 3704 3705 3706 3707 3708 3709 3710 3711 3712 3713 3714 3715 3716 3717 3718 3719 3720 3721 3722 3723 3724 ... 4023